BACKGROUND: The burden of dyslipidaemia is rising in many low income countries. However, there are few data on the prevalence of, or risk factors for, dyslipidaemia in Africa. METHODS: In 2011, we used the WHO Stepwise approach to collect cardiovascular risk data within a general population cohort in rural south-western Uganda. Dyslipidaemia was defined by high total cholesterol (TC) ≥ 5.2 mmol/L or low high density lipoprotein cholesterol (HDL-C) 6% (men aOR=3.00, 95%CI=1.37-6.59; women aOR=2.74, 95%CI=1.77-4.27). The odds of high TC was also higher among married men, and women with higher education or high BMI. CONCLUSION: Low HDL-C prevalence in this relatively young rural population is high whereas high TC prevalence is low. The consequ...
INTRODUCTION: Low high-density lipoprotein (HDL) is widely used as a marker of cardiovascular diseas...
BACKGROUND: Non-communicable diseases (NCDs) are rapidly becoming leading causes of morbidity and mo...
Dyslipidemia is a leading risk factor for atherosclerotic cardiovascular disease. There are few publ...
Background: The burden of dyslipidaemia is rising in many low income countries. However, there are f...
BACKGROUND: The burden of dyslipidaemia is rising in many low income countries. However, there are f...
BACKGROUND: Data on non-communicable disease (NCD) burden are often limited in developing countries ...
BACKGROUND: Dyslipidemia is a leading risk factor for atherosclerotic cardiovascular disease. There ...
Summary: Background: The burden of dyslipidaemia in Africa remains inadequately characterised. We a...
Background. Hypertension and dyslipidemia are independent risk factors for coronary heart disease an...
Dyslipidaemia is a primary risk factor for cardiometabolic disease, causing over 17 million deaths g...
OBJECTIVES: This study sought to assess the burden, pattern and predictors of dyslipidaemia in 425 a...
The present study assessed the prevalence, patterns and determinants of dyslipidaemia among South Af...
OBJECTIVE: Population-based data on burden of hypertension are crucial for planning and implementati...
Introduction: Low high-density lipoprotein (HDL) is widely used as a marker of cardiovascular diseas...
Dyslipidaemia is a primary risk factor for cardiometabolic disease, causing over 17 million deaths g...
INTRODUCTION: Low high-density lipoprotein (HDL) is widely used as a marker of cardiovascular diseas...
BACKGROUND: Non-communicable diseases (NCDs) are rapidly becoming leading causes of morbidity and mo...
Dyslipidemia is a leading risk factor for atherosclerotic cardiovascular disease. There are few publ...
Background: The burden of dyslipidaemia is rising in many low income countries. However, there are f...
BACKGROUND: The burden of dyslipidaemia is rising in many low income countries. However, there are f...
BACKGROUND: Data on non-communicable disease (NCD) burden are often limited in developing countries ...
BACKGROUND: Dyslipidemia is a leading risk factor for atherosclerotic cardiovascular disease. There ...
Summary: Background: The burden of dyslipidaemia in Africa remains inadequately characterised. We a...
Background. Hypertension and dyslipidemia are independent risk factors for coronary heart disease an...
Dyslipidaemia is a primary risk factor for cardiometabolic disease, causing over 17 million deaths g...
OBJECTIVES: This study sought to assess the burden, pattern and predictors of dyslipidaemia in 425 a...
The present study assessed the prevalence, patterns and determinants of dyslipidaemia among South Af...
OBJECTIVE: Population-based data on burden of hypertension are crucial for planning and implementati...
Introduction: Low high-density lipoprotein (HDL) is widely used as a marker of cardiovascular diseas...
Dyslipidaemia is a primary risk factor for cardiometabolic disease, causing over 17 million deaths g...
INTRODUCTION: Low high-density lipoprotein (HDL) is widely used as a marker of cardiovascular diseas...
BACKGROUND: Non-communicable diseases (NCDs) are rapidly becoming leading causes of morbidity and mo...
Dyslipidemia is a leading risk factor for atherosclerotic cardiovascular disease. There are few publ...